PURA Targets $4 Million In 2019 Sales
DALLAS, May 21, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) today announced filing its 2019 Q1 financial report. The first quarter report demonstrates sales consistent with the company’s 2018 annual revenue run rate which resulted in the company realizing over $1.2 million in total revenue in 2018. PURA’s revenue grew over 350% in 2018 compared to 2017. In addition to the PURA’s base sales reported in the first quarter derived primarily from the sale of the company’s cornerstone product, EVERx CBD Sports Water, PURA has signed an additional $1.5 million order for a private label CBD infused water. In consideration of the consistent base sales supporting over a $1 million annual revenue run rate, combined with the new $1.5 million private label CBD Infused water, and adding in a conservative growth rate, PURA management is now targeting $3 million in sales from CBD beverages alone. Management is targeting an additional $1 million in sales from new cannabis beverage sales the company is currently in the process of launching. The overall basic sales target for 2019 is $4 million. Management indicates that it has projects in the works that could result in PURA substantially exceeding its targets.
PURA Shareholder Dividend
PURA management also reiterates at this time it has recently updated its approach with Nouveau to deliver on the dividend of NOUV stock to PURA shareholders in conjunction with the 2018 Q4 spinoff of PURA’s cannabis cultivation operation to NOUV. A new website facilitating the acceleration of the dividend issuance process is to be launched imminently. In conjunction with the launch, PURA and NOUV management will detail the role of the website and further details with the updated dividend issuance strategy.
New EVERx CBD Sports Water Sales In Africa
PURA and Kali-Extracts (aka Kali, Inc.) wrapped up the in Johannesburg, South Africa featuring their EVERx CBD Sports Water this past weekend. KALY is a PURA partner with a patented cannabis extraction process licensed to PURA and instrumental in the production of EVERx. PURA management has declared the Arnold Sports Festival a success with an initial order to be delivered in South Africa resulting from the trade show. PURA will publish a report on the trade show later today that will include details on the latest order coming out of the trade show.
For more information on Puration, visit
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
(800) 861-1350
